Kindly MD (KDLY) Competitors $3.28 -0.94 (-22.27%) As of 09/4/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock KDLY vs. XGN, CORBF, DCGO, BNR, EUDA, QIPT, SERA, BDSX, ATPC, and PIIIShould you be buying Kindly MD stock or one of its competitors? The main competitors of Kindly MD include Exagen (XGN), Global Cord Blood (CORBF), DocGo (DCGO), Burning Rock Biotech (BNR), EUDA Health (EUDA), Quipt Home Medical (QIPT), Sera Prognostics (SERA), Biodesix (BDSX), Agape ATP (ATPC), and P3 Health Partners (PIII). These companies are all part of the "healthcare" industry. Kindly MD vs. Its Competitors Exagen Global Cord Blood DocGo Burning Rock Biotech EUDA Health Quipt Home Medical Sera Prognostics Biodesix Agape ATP P3 Health Partners Exagen (NASDAQ:XGN) and Kindly MD (NASDAQ:KDLY) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment. Do insiders & institutionals have more ownership in XGN or KDLY? 75.3% of Exagen shares are owned by institutional investors. 12.6% of Exagen shares are owned by company insiders. Comparatively, 50.5% of Kindly MD shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Do analysts recommend XGN or KDLY? Exagen presently has a consensus price target of $11.25, indicating a potential upside of 16.34%. Given Exagen's stronger consensus rating and higher probable upside, research analysts plainly believe Exagen is more favorable than Kindly MD.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Exagen 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00Kindly MD 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has stronger valuation & earnings, XGN or KDLY? Kindly MD has lower revenue, but higher earnings than Exagen. Exagen is trading at a lower price-to-earnings ratio than Kindly MD, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioExagen$55.64M3.82-$15.11M-$0.89-10.87Kindly MD$2.47M8.00-$4.64M-$0.77-4.26 Is XGN or KDLY more profitable? Kindly MD has a net margin of 0.00% compared to Exagen's net margin of -28.85%. Kindly MD's return on equity of 0.00% beat Exagen's return on equity.Company Net Margins Return on Equity Return on Assets Exagen-28.85% -130.38% -34.69% Kindly MD N/A N/A N/A Does the media favor XGN or KDLY? In the previous week, Exagen had 1 more articles in the media than Kindly MD. MarketBeat recorded 1 mentions for Exagen and 0 mentions for Kindly MD. Exagen's average media sentiment score of 1.47 beat Kindly MD's score of 0.00 indicating that Exagen is being referred to more favorably in the media. Company Overall Sentiment Exagen Positive Kindly MD Neutral SummaryKindly MD beats Exagen on 8 of the 15 factors compared between the two stocks. Get Kindly MD News Delivered to You Automatically Sign up to receive the latest news and ratings for KDLY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KDLY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KDLY vs. The Competition Export to ExcelMetricKindly MDHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$19.75M$61.91M$5.77B$9.91BDividend YieldN/AN/A6.71%4.52%P/E Ratio-4.26N/A75.5426.08Price / Sales8.003.46482.3289.52Price / CashN/A4.0236.9659.01Price / BookN/A1.1511.446.09Net Income-$4.64M-$30.80M$3.28B$266.14M7 Day Performance-44.69%-22.34%0.84%0.28%1 Month Performance-56.73%-28.36%7.15%4.14%1 Year Performance146.62%146.62%59.66%23.93% Kindly MD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KDLYKindly MDN/A$3.28-22.3%N/A+232.3%$19.75M$2.47M-4.26N/AXGNExagen4.5975 of 5 stars$9.85-2.5%$11.25+14.2%+233.2%$222.24M$55.64M-11.07220News CoveragePositive NewsShort Interest ↓CORBFGlobal Cord BloodN/A$1.60+3.2%N/A-40.0%$194.48M$196.12M0.001,200Gap UpDCGODocGo2.8225 of 5 stars$1.64-4.7%$3.59+118.9%-57.5%$168.23M$616.55M-8.634,407Positive NewsBNRBurning Rock Biotech0.6253 of 5 stars$8.60-7.9%N/A+77.9%$100.50M$523.28M-4.551,390Positive NewsEUDAEUDA Health0.5471 of 5 stars$2.67+2.7%N/A-66.1%$96.61M$4.01M0.002News CoverageShort Interest ↑QIPTQuipt Home Medical2.7884 of 5 stars$2.61+21.4%$3.15+20.7%-5.5%$93.40M$245.91M-10.871,200High Trading VolumeSERASera Prognostics1.4538 of 5 stars$2.64+10.9%N/A-54.0%$89.66M$80K-3.11120Short Interest ↓BDSXBiodesix3.6207 of 5 stars$0.49+8.0%$1.75+257.5%-75.8%$66.48M$71.32M-1.69220News CoveragePositive NewsInsider TradeATPCAgape ATP0.7956 of 5 stars$1.33+0.4%N/A-24.1%$66.01M$1.32M-3.2340Positive NewsShort Interest ↓Gap UpPIIIP3 Health Partners3.3057 of 5 stars$7.44+3.5%$16.25+118.4%-62.6%$51.68M$1.50B-0.16500Short Interest ↓ Related Companies and Tools Related Companies Exagen Alternatives Global Cord Blood Alternatives DocGo Alternatives Burning Rock Biotech Alternatives EUDA Health Alternatives Quipt Home Medical Alternatives Sera Prognostics Alternatives Biodesix Alternatives Agape ATP Alternatives P3 Health Partners Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KDLY) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kindly MD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kindly MD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
